Peripheral pterygium of eye, progressive
ICD-10 H11.05 is a used to indicate a diagnosis of peripheral pterygium of eye, progressive.
Peripheral pterygium of the eye, progressive, is characterized by a triangular-shaped growth of conjunctival tissue that extends onto the cornea, often leading to visual impairment. This condition typically arises due to chronic irritation from environmental factors such as UV exposure, dust, and wind. The anatomy involved includes the conjunctiva, which is the membrane covering the white part of the eye, the sclera, and the cornea. As the pterygium progresses, it can encroach upon the visual axis, potentially causing astigmatism or other refractive errors. Clinically, patients may present with symptoms such as redness, irritation, and a foreign body sensation. Diagnosis is primarily clinical, based on the appearance of the growth during a slit-lamp examination. In some cases, imaging may be utilized to assess the extent of the pterygium. Early intervention is crucial to prevent significant visual impairment, and treatment options may include lubricating eye drops, corticosteroid injections, or surgical excision in more advanced cases.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
H11.05 specifically covers progressive peripheral pterygium, which is characterized by the growth of conjunctival tissue onto the cornea. It is distinguished from non-progressive forms and other conjunctival lesions.
H11.05 should be used when there is clear evidence of progression of the pterygium affecting the cornea. If the pterygium is stable or non-progressive, H11.04 should be utilized instead.
Documentation should include a detailed clinical examination report, noting the size, location, and progression of the pterygium, as well as any symptoms reported by the patient. Treatment plans and follow-up notes are also essential.
